Work

2235P Chemotherapy priming leads to hypermutability and immune surveillance in colorectal cancer

Year: 2023

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.1263

Authors: P.P. Vitiello, R. Chilà, P. Battuello, V. Battaglieri, V. Amodio, G. Grasso, G. Rospo, S. Lamba, F. Pisati, B.J-C. Rousseau, L.A. Diaz, G. Crisafulli, F. Di Nicolantonio, G. Germano, A. Bardelli

Institutions: University of Turin, IFOM, Italian Association for Cancer Research, Candiolo Cancer Institute, Cogentech S.R.L. Società Benefit a Socio Unico soggetta all’attività di direzione e coordinamento di IFOM - Istituto Fondazione di Oncologia Molecolare ETS (Italy), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387812412

FWCI:

Cites:

Cited by:

Related to: 10